Literature DB >> 9369935

Characterization of the extracellular domain in vascular endothelial growth factor receptor-1 (Flt-1 tyrosine kinase).

K Tanaka1, S Yamaguchi, A Sawano, M Shibuya.   

Abstract

Flt-1 tyrosine kinase, vascular endothelial growth factor (VEGF) receptor-1, binds VEGF and a new VEGF-related ligand, placenta growth factor, but KDR/Flk-1 (VEGF receptor-2) binds only VEGF. To characterize the functional regions in the Flt-1 extracellular domain such as the ligand binding region and the dimer formation of the receptor, we constructed a series of mutants of the Flt-1 extracellular domain as soluble forms in a baculovirus system. We found that a region carrying the N-terminal 1st to 3rd immunoglobulin (Ig)-like domains of Flt-1 binds both ligands with high affinity. However, for dimer formation of soluble Flt-1, a region further downstream in the Flt-1 extracellular domain was required. Mutant Flt-1 receptors expressed in COS cells confirmed the requirement of the 4th to 7th Ig region for the activation of Flt-1 tyrosine kinase. Soluble Flt-1 carrying the N-terminal 1st to 3rd Ig region suppressed VEGF-dependent endothelial proliferation in vitro to the same level as the larger forms of soluble Flt-1, suggesting that the binding of one soluble Flt-1 molecule to one subunit of the VEGF homodimer may be sufficient to block the VEGF activity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9369935      PMCID: PMC5921513          DOI: 10.1111/j.1349-7006.1997.tb00463.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  30 in total

Review 1.  Growth factor signaling by receptor tyrosine kinases.

Authors:  J Schlessinger; A Ullrich
Journal:  Neuron       Date:  1992-09       Impact factor: 17.173

2.  Biochemical studies on liver functions in primary cultured hepatocytes of adult rats. I. Hormonal effects on cell viability and protein synthesis.

Authors:  K Tanaka; M Sato; Y Tomita; A Ichihara
Journal:  J Biochem       Date:  1978-10       Impact factor: 3.387

3.  The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis.

Authors:  M Clauss; H Weich; G Breier; U Knies; W Röckl; J Waltenberger; W Risau
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

4.  High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis.

Authors:  B Millauer; S Wizigmann-Voos; H Schnürch; R Martinez; N P Møller; W Risau; A Ullrich
Journal:  Cell       Date:  1993-03-26       Impact factor: 41.582

5.  Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.

Authors:  D Maglione; V Guerriero; G Viglietto; P Delli-Bovi; M G Persico
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

6.  Flt-1 but not KDR/Flk-1 tyrosine kinase is a receptor for placenta growth factor, which is related to vascular endothelial growth factor.

Authors:  A Sawano; T Takahashi; S Yamaguchi; M Aonuma; M Shibuya
Journal:  Cell Growth Differ       Date:  1996-02

7.  Stimulation of growth of primary cultured adult rat hepatocytes without growth factors by coculture with nonparenchymal liver cells.

Authors:  S Shimaoka; T Nakamura; A Ichihara
Journal:  Exp Cell Res       Date:  1987-09       Impact factor: 3.905

8.  A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1).

Authors:  A Yamane; L Seetharam; S Yamaguchi; N Gotoh; T Takahashi; G Neufeld; M Shibuya
Journal:  Oncogene       Date:  1994-09       Impact factor: 9.867

9.  A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growth factor VEGF.

Authors:  L Seetharam; N Gotoh; Y Maru; G Neufeld; S Yamaguchi; M Shibuya
Journal:  Oncogene       Date:  1995-01-05       Impact factor: 9.867

10.  Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies.

Authors:  W Risau; H Sariola; H G Zerwes; J Sasse; P Ekblom; R Kemler; T Doetschman
Journal:  Development       Date:  1988-03       Impact factor: 6.868

View more
  19 in total

1.  VEGF and Notch in tip and stalk cell selection.

Authors:  Raquel Blanco; Holger Gerhardt
Journal:  Cold Spring Harb Perspect Med       Date:  2013-01-01       Impact factor: 6.915

Review 2.  Vascular endothelial growth factor receptor-2 in breast cancer.

Authors:  Shanchun Guo; Laronna S Colbert; Miles Fuller; Yuanyuan Zhang; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2010-05-11

Review 3.  Targeted therapy with bevacizumab (Avastin) for metastatic colorectal cancer.

Authors:  G V Koukourakis; A Sotiropoulou-Lontou
Journal:  Clin Transl Oncol       Date:  2011-10       Impact factor: 3.405

Review 4.  Therapeutic potential of manipulating VEGF splice isoforms in oncology.

Authors:  Emma S Rennel; Steven J Harper; David O Bates
Journal:  Future Oncol       Date:  2009-06       Impact factor: 3.404

5.  Targeted therapies in the management of colorectal carcinoma: role of bevacizumab.

Authors:  Ajithkumar Puthillath; Anush Patel; Marwan G Fakih
Journal:  Onco Targets Ther       Date:  2009-02-18       Impact factor: 4.147

6.  Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice.

Authors:  S Hiratsuka; O Minowa; J Kuno; T Noda; M Shibuya
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

7.  Soluble VEGFR1 signaling guides vascular patterns into dense branching morphologies.

Authors:  Dóra Lakatos; Ellák Somfai; Előd Méhes; András Czirók
Journal:  J Theor Biol       Date:  2018-08-04       Impact factor: 2.691

Review 8.  VEGFR and type-V RTK activation and signaling.

Authors:  Masabumi Shibuya
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-10-01       Impact factor: 10.005

9.  Computational modeling of interacting VEGF and soluble VEGF receptor concentration gradients.

Authors:  Yasmin L Hashambhoy; John C Chappell; Shayn M Peirce; Victoria L Bautch; Feilim Mac Gabhann
Journal:  Front Physiol       Date:  2011-10-04       Impact factor: 4.566

10.  Involvement of Flt-1 (VEGF receptor-1) in cancer and preeclampsia.

Authors:  Masabumi Shibuya
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.